North Stonington, CT, United States of America

Martin Patrick Allen

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Pfizer Corporation, Neurogen Corporation. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Patrick Allen. Retrieved from https://idiyas.com/inventor/martin-patrick-allen-ojcu2t70

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 25.0


Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Voluntown, CT (US) (2007)
  • North Stonington, CT (US) (2003 - 2010)

Company Filing History:


Years Active: 2003-2010

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Martin Patrick Allen: Innovator in Pharmaceutical Chemistry

Introduction

Martin Patrick Allen is a notable inventor based in North Stonington, Connecticut. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. His work primarily focuses on compounds that have potential applications in treating central nervous system diseases.

Latest Patents

One of his latest patents involves benzimidazole and pyridylimidazole derivatives. This invention relates to compounds that bind with high selectivity and affinity to the benzodiazepine site of GABA receptors. The invention also encompasses pharmaceutical compositions that include these compounds and their use in treating certain central nervous system diseases. Additionally, novel processes for preparing these compounds are disclosed. Another significant patent pertains to pyrazole compounds aimed at treating neurodegenerative disorders. These compounds inhibit the production of Aβ-peptide and provide methods for treating diseases such as Alzheimer's in mammals.

Career Highlights

Throughout his career, Martin has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Neurogen Corporation. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Martin has collaborated with notable professionals in his field, including Spiros Liras and Guiying Li. These partnerships have further enhanced his research and development efforts.

Conclusion

Martin Patrick Allen's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to impact the treatment of central nervous system diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…